Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study
Keywords:skin cancer, adverse effect, photosensitivity, diuretic, carcinogenicity
Abstract is missing (Correspondence)
Haisma MS, Greven N, Logendran M, Bos J, Vegt B van der, Horváth B, et al. Chronic use of hydrochlorothiazide and risk of skin cancer in Caucasian adults: a PharmLines initiative inception cohort study. Acta Derm Venereol 2023; 103: adv3933.
Lee RJ, Madan RA, Kim J, Posadas EM, Yu EY. Disparities in cancer care and the Asian American population. Oncologist 2021; 26: 453-460.
Bright HR, Chandy SJ, George R, Thomas M, Rajkumar P, George A. Long-term hydrochlorothiazide use and risk of cutaneous neoplasms. Curr Med Issues 2021; 19: 264.
Pottegård A, Pedersen SA, Schmidt SAJ, Lee CN, Hsu CK, Liao TC, et al. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study. Br J Cancer 2019; 121: 973-978.
Park E, Lee Y, Jue MS. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea. Korean J Intern Med 2020; 35: 917-928.
How to Cite
Copyright (c) 2023 Heber Rew Bright, Sujith J. Chandy, Renu George
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.